A new challenge has emerged for U.S. medical device exporters just before August 1.
Notification: The U.S. FDA annual registration fee for medical devices will increase from 9,280to11,423, effective October 1, 2025 (FY2026). This marks the largest fee hike in history.
Additionally, the criteria for small business exemptions/reduced fees have been released (see image below) – details available upon consultation.
Based on 2025 export data and industry reports, Chinese medical device exports to the U.S. primarily include low-value consumables, home-use devices, and select high-end equipment. Below is a category-by-category breakdown of core exported products. Cross-border traders involved in U.S. medical device exports should prepare in advance for these trends:
I. Low-Value Consumables & Dressings (Traditional Strength)
Syringes, Needles, and Catheters: Leading in export value, with over $224 million exported to the U.S. in Q1 2025. However, rising U.S. tariffs (now 50%) have significantly increased costs.
Medical Dressings (Gauze, Bandages, Cotton Wool): Annual exports total ~$769 million, widely used in emergency and surgical settings.
Medical Gloves (Including Rubber Gloves): Annual exports reach $442 million. Tariffs rose to 25% in 2024 and may increase further in 2026.
II. Home-Use & Monitoring Devices (Fast-Growing Category)
Oxygen Concentrators & Ventilators: Represented by Yuwell Medical, exports of home ventilators grew by over 15%. Emergency products with EU certifications have boosted U.S. sales.
Thermometers & Blood Pressure Monitors: Stable demand for home monitoring devices (FDA Class II), requiring 510(k) clearance.
Massage Devices (Neck/Shoulder/Eye Massagers): Standard massage devices need FCC certification; those claiming "pain relief" require FDA Class II approval.
III. High-End Medical Devices (Technological Breakthroughs)
Endoscopes: Export value surged 41.25% YoY in Q1 2025, emerging as a star product, primarily sold to the U.S. and EU.
Medical Imaging Equipment (Ultrasound, Monitors): Mindray's monitors and United Imaging's CT scanners are accelerating global expansion. AI-assisted diagnosis features enhance competitiveness.
Surgical Robots: MicroPort's laparoscopic robot (Toumai) is challenging Intuitive Surgical's da Vinci dominance, targeting 500 installations in 2025. Neurointerventional devices are also gaining traction.
IV. Categories Significantly Impacted by Tariffs & Compliance
Tariff-Sensitive Products:
Ventilator Components: Combined tariffs now reach 35%.
Orthopedic Implants (Joints, Bone Screws): Weigao Group's products face tariff pressure, but 3D printing upgrades are helping maintain exports.
High-Compliance-Risk Products:
Beauty Devices (RF/Laser): Classified as FDA Class II, requiring 510(k) clearance. Labels must specify "For Sale Only to Licensed Physicians."
Electrical Pulse Therapies (e.g., TENS Devices): Mislabeling "therapeutic" functions can lead to FDA detention.
Summary & Trends
Core Categories: Low-value consumables (syringes, dressings) and home devices (ventilators, thermometers) remain the export foundation but face dual challenges: U.S. tariffs (some exceeding 50%) and FDA compliance.
Emerging Growth Drivers: High-end devices like endoscopes, AI imaging (Shukun Tech), and surgical robots (Tianzhihang) are breaking through technical barriers, becoming structural growth engines.
Corporate Strategies: Leading firms (Mindray, MicroPort) are mitigating tariffs via mergers, acquisitions, and local production (e.g., factories in Vietnam) while accelerating FDA certifications to secure market access.
Professionalism drives success – we specialize in cross-border supply chain collaboration, including FDA/EU CE compliance consulting, organic certifications (EU/U.S.), Halal/Kosher certifications, SQF facility audits, FSVP supplier program certifications, CCPIT certificates, Free Sale Certificates, MSDS reports, air/sea transport certifications, and UN38.3 testing.
